Neutrophil Gelatinase B–associated Lipocalin and Matrix Metalloproteinase-9 Complex as a Surrogate Serum Marker of Mucosal Healing in Ulcerative Colitis
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Neutrophil Gelatinase B–associated Lipocalin and Matrix Metalloproteinase-9 Complex as a Surrogate Serum Marker of Mucosal Healing in Ulcerative Colitis
Authors
Keywords
-
Journal
INFLAMMATORY BOWEL DISEASES
Volume 20, Issue 7, Pages 1198-1207
Publisher
Oxford University Press (OUP)
Online
2014-05-28
DOI
10.1097/mib.0000000000000068
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neutrophil Gelatinase-Associated Lipocalin Levels in Patients With Crohn Disease Undergoing Treatment With Infliximab
- (2016) Davide Bolignano et al. JOURNAL OF INVESTIGATIVE MEDICINE
- EMerging BiomARKers in Inflammatory Bowel Disease (EMBARK) Study Identifies Fecal Calprotectin, Serum MMP9 and Serum IL-22 as a Novel Combination of Biomarkers for Crohn's Disease Activity: Role of Cross-Sectional Imaging
- (2013) William A Faubion et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): The next decade
- (2013) Jennifer Vandooren et al. CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Relationship Between Neutrophil Gelatinase-Associated Lipocalin (NGAL) Levels and Inflammatory Bowel Disease Type and Activity
- (2013) Atakan Yeşil et al. DIGESTIVE DISEASES AND SCIENCES
- Fecal calprotectin, MMP-9, and human beta-defensin-2 levels in pediatric inflammatory bowel disease
- (2013) Kaija-Leena Kolho et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Zymography methods for visualizing hydrolytic enzymes
- (2013) Jennifer Vandooren et al. NATURE METHODS
- Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease
- (2012) Geert DʼHaens et al. INFLAMMATORY BOWEL DISEASES
- Fecal MMP-9
- (2012) Anita Annaházi et al. INFLAMMATORY BOWEL DISEASES
- Neutrophil Gelatinase-associated Lipocalin (NGAL) Expression Is Dependent on the Tumor-associated Sigma-2 Receptor S2RPgrmc1
- (2012) Shakeel U. R. Mir et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Biomarkers in inflammatory bowel disease: current practices and recent advances
- (2012) Heba N. Iskandar et al. Translational Research
- Etiology of inflammatory bowel disease: A unified hypothesis
- (2012) Xiaofa Qin WORLD JOURNAL OF GASTROENTEROLOGY
- Neutrophil gelatinase-associated lipocalin (NGAL) in inflammatory bowel disease: association with pathophysiology of inflammation, established markers, and disease activity
- (2011) K. A. Oikonomou et al. JOURNAL OF GASTROENTEROLOGY
- Antibodies targeting the catalytic zinc complex of activated matrix metalloproteinases show therapeutic potential
- (2011) Netta Sela-Passwell et al. NATURE MEDICINE
- Neutrophils, from Marrow to Microbes
- (2010) Niels Borregaard IMMUNITY
- Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: A new protein enters the scene
- (2009) Davide Bolignano et al. CANCER LETTERS
- Lipocalin 2 Is Required for Pulmonary Host Defense against Klebsiella Infection
- (2009) Y. R. Chan et al. JOURNAL OF IMMUNOLOGY
- Mucosal Gene Expression of Antimicrobial Peptides in Inflammatory Bowel Disease Before and After First Infliximab Treatment
- (2009) Ingrid Arijs et al. PLoS One
- Increased incidence of urinary matrix metalloproteinases as predictors of disease in pediatric patients with inflammatory bowel disease
- (2008) Michael A. Manfredi et al. INFLAMMATORY BOWEL DISEASES
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started